发明名称 |
STEROL-BASE COMPOSITION (VARIANTS) AND METHOD OF REDUCTION OF HUMAN BLOOD TOTAL CHOLESTEROL AND LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL (VARIANTS) |
摘要 |
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to composition (variants) including vegetable sterol and soybean protein matter and/or isoflavone taken among genistein, daidzein, glycetein, biochanin A, formononetin and their natural glycosides being vegetable sterol comprises at least 0.49% of composition weight. Invention represents also method of reduction of blood total and low density lipoprotein chlolesterol content in humans (variants) where vegetable sterol and soybean protein matter and/or isoflavone are prescribed to humans (simultaneously). The dose of vegetable sterol is at least 0.49% of total weight of vegetable sterol and soybean matter and/or isoflavone. Invention relates also to method of prophylaxis or minimization of atherosclerosis development in human that involves prescription of vegetable sterol and soybean matter and/or isoflavone to humans in combination (simultaneously) being the dose of vegetable sterol is at least 0.49% of total weight of vegetable sterol and soybean protein matter and/or isoflavone. Invention provides reduction of risk of atherosclerosis and coronary insufficiency development in humans. EFFECT: enhanced effectiveness and valuable medicinal properties of composition. 32 cl, 4 dwg |
申请公布号 |
RU2205015(C2) |
申请公布日期 |
2003.05.27 |
申请号 |
RU20000109723 |
申请日期 |
2000.04.21 |
申请人 |
PROUTIN TEKNOLODZHIS INTERNEHSHNL, INK. |
发明人 |
UAGGLI DOUL' KH.;POTTER SJUZAN M.;KHENLI E.S. |
分类号 |
A23L2/38;A23J3/16;A23L1/30;A23L1/305;A23L2/52;A61K9/08;A61K9/14;A61K9/20;A61K9/48;A61K31/352;A61K31/575;A61K31/7048;A61K31/78;A61K36/48;A61P3/06;A61P9/00;A61P9/10;C07D311/30;C07J75/00 |
主分类号 |
A23L2/38 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|